Dr. Massarelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Bradbury, CA 91010Phone+1 713-792-6161
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2013
- Methodist Hospital (Houston)Residency, Internal Medicine, 2007 - 2009
- University of Naples Faculty of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 2016 - 2025
- TX State Medical License 2012 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- 184 citationsInduction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: Results from a phase II prospective trialMerrill S. Kies, F.C. Holsinger, J. Jack Lee, William N. William, Bonnie S. Glisson
Journal of Clinical Oncology. 2010-01-01 - 16 citationsWeekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced h...Robert I. Haddad, Erminia Massarelli, J. Jack Lee, H. Lin, Katherine A. Hutcheson
Annals of Oncology. 2019-03-01 - 68 citationsPhase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinomaErminia Massarelli, H. Lin, Lawrence E. Ginsberg, Hai T. Tran, J. Jack Lee
Annals of Oncology. 2015-07-01
Journal Articles
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients with Incurable Human Papillomavirus 16–Related CancerErminia Massarelli, William William, Ming Guo, Merrill Kies, Bonnie Glisson, Hai Tran, Faye Johnson, Renata Ferrarotto, Lei Feng, JAMA
Press Mentions
- Business Digest: UT Health Expands Services in TylerSeptember 10th, 2024
- City of Hope Now Enrolling Patients for First-in-Human T Cell Trial for HPV-Associated CancersAugust 15th, 2019
- Expert Discusses Treatment Advances in ALK-Positive NSCLCJanuary 9th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: